U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07865988) titled 'Efficacy of High-Dose Melatonin in Alleviating Radiotherapy-Induced Fatigue in Breast Cancer Patients: A Randomized Phase II Trial' on Oct. 03.
Brief Summary: To assess the role of High-Dose Melatonin in Alleviating Radiotherapy-Induced Fatigue in Breast Cancer Patients. The primary end point is assessment of fatigue severity . Secondary end points Assessment of skin toxicity to evaluate melatonin's secondary radioprotective benefits
Study Start Date: Oct. 02, 2024
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Radiotherapy Induced Fatigue
Intervention:
DRUG: Melatonin
for melatonin group (experimental) :Oral administrati...